Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
192 participants
INTERVENTIONAL
2018-08-28
2021-11-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Supporting Families in the ICU
NCT07228299
Comprehensive Support for Alzheimer's Disease Caregivers
NCT00362284
Promoting the Well Being of Caregivers Via Telehealth
NCT05999448
Caregiver Outlook: An Evidence-based Intervention for the Chaplain Toolkit
NCT01768221
Telephone-Based Support for Caregivers of Patients With Dementia
NCT00052104
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The specific aims of this proposed study are:
1. To determine the effect of the spiritual care intervention on psychological well-being for family surrogates at 3 months post discharge, including anxiety (primary outcome: GAD-7), depression (PHQ-9), Posttraumatic stress (IES-R), and overall distress.
2. To determine the effect of the spiritual care intervention on spiritual well-being for family surrogates, (FACIT-SP- non-illness) and on religious coping (Brief RCOPE positive and negative).
3. To determine the effects of the spiritual care intervention on other aspects of the surrogates' experience, including satisfaction with spiritual care (Patient Satisfaction Instrument--Chaplaincy) communication (FICS), overall satisfaction with the hospital stay (Picker single item) and decision conflict (DCS).
4. To determine the effect of the intervention on treatment at the end of life (life sustaining treatments and hospice utilization) for patients who die in the hospital.
5. To determine differences in outcomes between the intervention group, who will receive our intervention, and the control group, who will receive the usual care provided by the hospital chaplaincy service.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control (Usual Care)
Surrogate will receive usual care in the hospital, which could include visits from the unit chaplain or other staff from the spiritual care department.
No interventions assigned to this group
Intervention
Spiritual Care Assessment and Intervention (SCAI) framework
Spiritual Care Assessment and Intervention (SCAI) framework
The study chaplain will work with the surrogate, using questions in four domains of spiritual care, to assess them and tailor the visit to their specific needs. The study chaplain will then utilize a pre-determined list of spiritual care interventions, and also document observable outcomes that occur at each visit (which are also listed within the SCAI framework).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Spiritual Care Assessment and Intervention (SCAI) framework
The study chaplain will work with the surrogate, using questions in four domains of spiritual care, to assess them and tailor the visit to their specific needs. The study chaplain will then utilize a pre-determined list of spiritual care interventions, and also document observable outcomes that occur at each visit (which are also listed within the SCAI framework).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Patient is not decisional due to:
Exclusion Criteria
* Unresponsive
* otherwise unable to communicate (AMS, dementia, delirium, etc.)
Decision Support Requirements
2. Patient has a qualified surrogate decision maker
* Intubated for surgery and expected to be extubated within 24 hours
* Imminently dying as evidenced by patient notes
* Patient and/or family have a care contract or other restriction due to complicated or volatile situation
* Patient is a prisoner
* Patient is being followed by Adult Protective Services (APS)
* Patient meets cognitive criteria but does not have a qualified surrogate decision maker
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Regenstrief Institute, Inc.
OTHER
Indiana University Health
OTHER
Indiana University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alexia M. Torke
Associate Professor of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alexia M Torke, MD, MS
Role: PRINCIPAL_INVESTIGATOR
Indiana University, IU Health, Regenstrief Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IU Health Methodist Hospital
Indianapolis, Indiana, United States
IU Health University Hospital
Indianapolis, Indiana, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Torke AM, Varner-Perez SE, Burke ES, Taylor TA, Slaven JE, Kozinski KL, Maiko SM, Pfeffer BJ, Banks SK. Effects of Spiritual Care on Well-Being of Intensive Care Family Surrogates: A Clinical Trial. J Pain Symptom Manage. 2023 Apr;65(4):296-307. doi: 10.1016/j.jpainsymman.2022.12.007. Epub 2022 Dec 14.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1806775750
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.